Location: Home
  • search
  • go
  • Relate News
  • 2/3/2026SanegeneBio Strikes Global RNAi Licensing Deal With Genentech Worth Up...
  • 2/3/2026Zenshine Files for Hong Kong IPO to Fuel Expansion Across Infectious D...
  • 2/3/2026China Tightens BMI Fund Oversight for 2026 With Nationwide Crackdown o...
  • 2/3/2026China and USFDA Officials Pledge to Deepen Regulatory Cooperation at B...
  • 2/3/2026Newsoara Expands Global Footprint With $135M Deal for vTv's Inflammati...
  • 1/31/2026China's Vaccine Exports Jump More Than 50% in 2025 as Overseas Shipmen...
  • 1/31/2026Recent Official and Executive Moves
  • 1/30/2026AstraZeneca Expands Obesity Pipeline Through $18.5B CSPC Collaboration
  • 1/30/2026Formation Bio Licenses Oral miR-124 Activator FHND5032 from CTFH for A...
  • 1/30/2026SciBrunch Raises Over $35M in Oversubscribed Pre-A Round
  • 1/30/2026Sciwind Receives China Approval for Ecnoglutide Injection in Type 2 Di...
  • 1/30/2026CMS Secures NMPA Approval for Opzelura in Non-Segmental Vitiligo
  • 1/30/2026CSPC's SYS6055 Becomes First In Vivo CAR-T Therapy Approved for Clinic...
  • 1/30/2026Roche's 2025 Results Highlight Strong China Growth amid Global Expansi...
  • 1/30/2026CDE Issues Trial Guideline to Standardize Clinical Development of Anti...
  • 1/30/2026CDE Issues New Clinical Trial Guideline for Antifibrotic Drugs in Inte...
  • 1/30/2026China Releases New Guideline on CMC Changes for Cell Therapy Products
  • 1/30/2026China Solicits Comments on 103rd Batch of Reference Formulations for C...
  • 1/30/2026China's Basic Medical Insurance Fund Posts Solid Surplus in 2025 as In...
  • 1/29/2026AstraZeneca Deepens China Commitment With $15B Investment
  • 1/29/2026Best-Link Bio Raises Over CNY 200M in Series B to Advance Nanoconjugat...
  • 1/29/2026NeuShen Thera Raises US$ Tens of Mlns in Series A+ Financing Led by Li...
  • 1/29/2026Novartis Wins Expanded China Approval for Leqvio
  • 1/29/2026The United Labs Secures U.S. FDA IND Clearance for Novel β-Lactamase ...
  • 1/29/2026Sciwind Reports Positive Phase III Results for Ecnoglutide in T2DM
  • 1/29/2026Phase III Trial Shows Anbenitamab Significantly Improves Survival in H...
  • 1/29/2026China's Innovation in Translational Medicine: Rethinking Early-stage C...
  • 1/28/2026NMPA Releases 101st Batch of Reference Formulations for Generic Drug E...
  • 1/28/2026CDE Issues New Technical Guidance for Clinical Trials of Long-Acting L...
  • 1/28/2026China Issues Trial Guidance on Pharmaceutical Research for Preventive ...
  • Page:1/814 Total number of articles:24420: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group